| 1 | [SID103215315] | Active | IC50 | 9 | Inhibition of lipid peroxidation in Sprague-Dawley rat heart mitochondria assessed as inhibition of FeSO4-induced malondialdehyde formation [AID398697, Type: other] | |  View X | Row No. | 1 | | Structure | 
| | Substance | | | SID | 103215315 | | CID | 122738 | | Outcome | Active | | IC50 | 9 [uM] | | BioAssay | Inhibition of lipid peroxidation in Sprague-Dawley rat heart mitochondria assessed as inhibition of FeSO4-induced malondialdehyde formation | | AID | 398697 | | BioAssay type | other | | Target | | | PubMed | | | Data Table | |
|
| 2 | [SID103215315] | Active | IC50 | 10.5 | Antioxidant activity assessed as superoxide radical anion scavenging activity [AID380203, Type: Literature] | |  View X | Row No. | 2 | | Structure |
| | Substance | | | SID | 103215315 | | CID | 122738 | | Outcome | Active | | IC50 | 10.5 [uM] | | BioAssay | Antioxidant activity assessed as superoxide radical anion scavenging activity | | AID | 380203 | | BioAssay type | Literature | | Target | | | PubMed | 10425115 | | Data Table | |
|
| 3 | [SID103215315] | Active | IC50 | 11 | Inhibition of lipid peroxidation in Sprague-Dawley rat heart mitochondria assessed as inhibition of FeSO4-induced oxygen consumption [AID398696, Type: other] | | View X | Row No. | 3 | | Structure |
| | Substance | | | SID | 103215315 | | CID | 122738 | | Outcome | Active | | IC50 | 11 [uM] | | BioAssay | Inhibition of lipid peroxidation in Sprague-Dawley rat heart mitochondria assessed as inhibition of FeSO4-induced oxygen consumption | | AID | 398696 | | BioAssay type | other | | Target | | | PubMed | | | Data Table | |
|
| 4 | [SID103215315] | Unspecified | IC50 | 25 | Anti-HIV activity in cell culture assay expressed as IC50 values. [AID81601, Type: other] | | View X | Row No. | 4 | | Structure |
| | Substance | | | SID | 103215315 | | CID | 122738 | | Outcome | Unspecified | | IC50 | 25 [uM] | | BioAssay | Anti-HIV activity in cell culture assay expressed as IC50 values. | | AID | 81601 | | BioAssay type | other | | Target | | | PubMed | | | Data Table | |
|
| 5 | [SID103215315] | Unspecified | EC50 | 25 | Anti-HIV activity in cell culture assay expressed as EC50 values. [AID81248, Type: other] | | View X | Row No. | 5 | | Structure |
| | Substance | | | SID | 103215315 | | CID | 122738 | | Outcome | Unspecified | | EC50 | 25 [uM] | | BioAssay | Anti-HIV activity in cell culture assay expressed as EC50 values. | | AID | 81248 | | BioAssay type | other | | Target | | | PubMed | | | Data Table | |
|
| 6 | [SID103215315] | Unspecified | IC50 | 58 | Modulation of classical complement pathway system assessed as hemoglobin release by spectrophotometry [AID380219, Type: Literature] | | View X | Row No. | 6 | | Structure |
| | Substance | | | SID | 103215315 | | CID | 122738 | | Outcome | Unspecified | | IC50 | 58 [uM] | | BioAssay | Modulation of classical complement pathway system assessed as hemoglobin release by spectrophotometry | | AID | 380219 | | BioAssay type | Literature | | Target | | | PubMed | 10425115 | | Data Table | |
|
| 7 | [SID103215315] | Unspecified | | | Antiviral activity against HIV infected in human MT4 cells assessed as inhibition of virus-induced cytopathic effect by MTT assay [AID380207, Type: Literature] | | View X | Row No. | 7 | | Structure |
| | Substance | | | SID | 103215315 | | CID | 122738 | | Outcome | Unspecified | | BioAssay | Antiviral activity against HIV infected in human MT4 cells assessed as inhibition of virus-induced cytopathic effect by MTT assay | | AID | 380207 | | BioAssay type | Literature | | Target | | | PubMed | 10425115 | | Data Table | |
|
| 8 | [SID103215315] | Unspecified | | | Antimicrobial activity against Mycobacterium fortuitum [AID380214, Type: Literature] | | View X | Row No. | 8 | | Structure |
| | Substance | | | SID | 103215315 | | CID | 122738 | | Outcome | Unspecified | | BioAssay | Antimicrobial activity against Mycobacterium fortuitum | | AID | 380214 | | BioAssay type | Literature | | Target | | | PubMed | 10425115 | | Data Table | |
|
| 9 | [SID103215315] | Unspecified | | | Antimicrobial activity against Enterobacter cloacae [AID380215, Type: Literature] | | View X | Row No. | 9 | | Structure |
| | Substance | | | SID | 103215315 | | CID | 122738 | | Outcome | Unspecified | | BioAssay | Antimicrobial activity against Enterobacter cloacae | | AID | 380215 | | BioAssay type | Literature | | Target | | | PubMed | 10425115 | | Data Table | |
|
| 10 | [SID103215315] | Unspecified | | | Antimicrobial activity against Salmonella paratyphi [AID380216, Type: Literature] | | View X | Row No. | 10 | | Structure |
| | Substance | | | SID | 103215315 | | CID | 122738 | | Outcome | Unspecified | | BioAssay | Antimicrobial activity against Salmonella paratyphi | | AID | 380216 | | BioAssay type | Literature | | Target | | | PubMed | 10425115 | | Data Table | |
|
| 11 | [SID103215315] | Unspecified | | | Antimicrobial activity against Pseudomonas aeruginosa [AID380217, Type: Literature] | | View X | Row No. | 11 | | Structure |
| | Substance | | | SID | 103215315 | | CID | 122738 | | Outcome | Unspecified | | BioAssay | Antimicrobial activity against Pseudomonas aeruginosa | | AID | 380217 | | BioAssay type | Literature | | Target | | | PubMed | 10425115 | | Data Table | |
|
| 12 | [SID103215315] | Unspecified | | | Antimicrobial activity against Escherichia coli [AID380218, Type: Literature] | | View X | Row No. | 12 | | Structure |
| | Substance | | | SID | 103215315 | | CID | 122738 | | Outcome | Unspecified | | BioAssay | Antimicrobial activity against Escherichia coli | | AID | 380218 | | BioAssay type | Literature | | Target | | | PubMed | 10425115 | | Data Table | |
|
| 13 | [SID103215315] | Unspecified | | | Cytotoxicity against human MT4 cells by MTT assay [AID380205, Type: Literature] | | View X | Row No. | 13 | | Structure |
| | Substance | | | SID | 103215315 | | CID | 122738 | | Outcome | Unspecified | | BioAssay | Cytotoxicity against human MT4 cells by MTT assay | | AID | 380205 | | BioAssay type | Literature | | Target | | | PubMed | 10425115 | | Data Table | |
|
| 14 | [SID103215315] | Unspecified | | | Selectivity index, ratio of CC50 for human MT4 cells to IC50 for HIV infected in human MT4 cells [AID380206, Type: Literature] | | View X | Row No. | 14 | | Structure |
| | Substance | | | SID | 103215315 | | CID | 122738 | | Outcome | Unspecified | | BioAssay | Selectivity index, ratio of CC50 for human MT4 cells to IC50 for HIV infected in human MT4 cells | | AID | 380206 | | BioAssay type | Literature | | Target | | | PubMed | 10425115 | | Data Table | |
|
| 15 | [SID103215315] | Unspecified | | | Inhibition against HIV replication in cell culture at 20 ug/mL [AID81794, Type: other] | | View X | Row No. | 15 | | Structure |
| | Substance | | | SID | 103215315 | | CID | 122738 | | Outcome | Unspecified | | BioAssay | Inhibition against HIV replication in cell culture at 20 ug/mL | | AID | 81794 | | BioAssay type | other | | Target | | | PubMed | | | Data Table | |
|
| 16 | [SID103215315] | Unspecified | | | Antimicrobial activity against Staphylococcus aureus after 24 hrs by disk diffusion method [AID336170, Type: Literature] | | View X | Row No. | 16 | | Structure |
| | Substance | | | SID | 103215315 | | CID | 122738 | | Outcome | Unspecified | | BioAssay | Antimicrobial activity against Staphylococcus aureus after 24 hrs by disk diffusion method | | AID | 336170 | | BioAssay type | Literature | | Target | | | PubMed | 12398535 | | Data Table | |
|
| 17 | [SID103215315] | Unspecified | | | Antimicrobial activity against Candida albicans after 24 hrs by disk diffusion method [AID336171, Type: Literature] | | View X | Row No. | 17 | | Structure |
| | Substance | | | SID | 103215315 | | CID | 122738 | | Outcome | Unspecified | | BioAssay | Antimicrobial activity against Candida albicans after 24 hrs by disk diffusion method | | AID | 336171 | | BioAssay type | Literature | | Target | | | PubMed | 12398535 | | Data Table | |
|
| 18 | [SID103215315] | Unspecified | | | Antiviral activity against Potato virus X in half leaf of Chenopodium quinoa at 9.3 mg/mL after 10 days [AID336178, Type: Literature] | | View X | Row No. | 18 | | Structure |
| | Substance | | | SID | 103215315 | | CID | 122738 | | Outcome | Unspecified | | BioAssay | Antiviral activity against Potato virus X in half leaf of Chenopodium quinoa at 9.3 mg/mL after 10 days | | AID | 336178 | | BioAssay type | Literature | | Target | | | PubMed | 12398535 | | Data Table | |
|
| 19 | [SID103215315] | Unspecified | | | Cytotoxicity against human PRMI7951 cells by tetrazolium salt-based colorimetric assay [AID358165, Type: other] | | View X | Row No. | 19 | | Structure |
| | Substance | | | SID | 103215315 | | CID | 122738 | | Outcome | Unspecified | | BioAssay | Cytotoxicity against human PRMI7951 cells by tetrazolium salt-based colorimetric assay | | AID | 358165 | | BioAssay type | other | | Target | | | PubMed | | | Data Table | |
|
| 20 | [SID103215315] | Unspecified | | | Cytotoxicity against human KB cells by tetrazolium salt-based colorimetric assay [AID358166, Type: other] | | View X | Row No. | 20 | | Structure |
| | Substance | | | SID | 103215315 | | CID | 122738 | | Outcome | Unspecified | | BioAssay | Cytotoxicity against human KB cells by tetrazolium salt-based colorimetric assay | | AID | 358166 | | BioAssay type | other | | Target | | | PubMed | | | Data Table | |
|
| 21 | [SID103215315] | Unspecified | | | Cytotoxicity against human A549 cells by tetrazolium salt-based colorimetric assay [AID358167, Type: other] | | View X | Row No. | 21 | | Structure |
| | Substance | | | SID | 103215315 | | CID | 122738 | | Outcome | Unspecified | | BioAssay | Cytotoxicity against human A549 cells by tetrazolium salt-based colorimetric assay | | AID | 358167 | | BioAssay type | other | | Target | | | PubMed | | | Data Table | |
|
| 22 | [SID103215315] | Unspecified | | | Cytotoxicity against human HCT8 cells by tetrazolium salt-based colorimetric assay [AID358168, Type: other] | | View X | Row No. | 22 | | Structure |
| | Substance | | | SID | 103215315 | | CID | 122738 | | Outcome | Unspecified | | BioAssay | Cytotoxicity against human HCT8 cells by tetrazolium salt-based colorimetric assay | | AID | 358168 | | BioAssay type | other | | Target | | | PubMed | | | Data Table | |
|
| 23 | [SID103215315] | Unspecified | | | Cytotoxicity against human TE671 cells by tetrazolium salt-based colorimetric assay [AID358169, Type: other] | | View X | Row No. | 23 | | Structure |
| | Substance | | | SID | 103215315 | | CID | 122738 | | Outcome | Unspecified | | BioAssay | Cytotoxicity against human TE671 cells by tetrazolium salt-based colorimetric assay | | AID | 358169 | | BioAssay type | other | | Target | | | PubMed | | | Data Table | |
|
| 24 | [SID103215315] | Unspecified | | | Inhibition of AMV reverse transcriptase activity assessed as incorporation of dTMP in poly(rA)-oligo(dT) at 0.1 uM [AID400984, Type: other] | | View X | Row No. | 24 | | Structure |
| | Substance | | | SID | 103215315 | | CID | 122738 | | Outcome | Unspecified | | BioAssay | Inhibition of AMV reverse transcriptase activity assessed as incorporation of dTMP in poly(rA)-oligo(dT) at 0.1 uM | | AID | 400984 | | BioAssay type | other | | Target | | | PubMed | | | Data Table | |
|
| 25 | [SID103215315] | Unspecified | | | Inhibition of AMV reverse transcriptase activity assessed as incorporation of dTMP in poly(rA)-oligo(dT) at 1 uM [AID400985, Type: other] | | View X | Row No. | 25 | | Structure |
| | Substance | | | SID | 103215315 | | CID | 122738 | | Outcome | Unspecified | | BioAssay | Inhibition of AMV reverse transcriptase activity assessed as incorporation of dTMP in poly(rA)-oligo(dT) at 1 uM | | AID | 400985 | | BioAssay type | other | | Target | | | PubMed | | | Data Table | |
|
| 26 | [SID103215315] | Unspecified | | | Inhibition of AMV reverse transcriptase activity assessed as incorporation of dTMP in poly(rA)-oligo(dT) at 10 uM [AID400986, Type: other] | | View X | Row No. | 26 | | Structure |
| | Substance | | | SID | 103215315 | | CID | 122738 | | Outcome | Unspecified | | BioAssay | Inhibition of AMV reverse transcriptase activity assessed as incorporation of dTMP in poly(rA)-oligo(dT) at 10 uM | | AID | 400986 | | BioAssay type | other | | Target | | | PubMed | | | Data Table | |
|
| 27 | [SID103215315] | Unspecified | | | Inhibition of AMV reverse transcriptase activity assessed as incorporation of dTMP in poly(rA)-oligo(dT) at 100 uM [AID400987, Type: other] | | View X | Row No. | 27 | | Structure |
| | Substance | | | SID | 103215315 | | CID | 122738 | | Outcome | Unspecified | | BioAssay | Inhibition of AMV reverse transcriptase activity assessed as incorporation of dTMP in poly(rA)-oligo(dT) at 100 uM | | AID | 400987 | | BioAssay type | other | | Target | | | PubMed | | | Data Table | |
|
| 28 | [SID103215315] | Unspecified | | | Inhibition of AMV reverse transcriptase activity assessed as incorporation of dTMP in poly(rA)-oligo(dT) at 1000 uM [AID400988, Type: other] | | View X | Row No. | 28 | | Structure |
| | Substance | | | SID | 103215315 | | CID | 122738 | | Outcome | Unspecified | | BioAssay | Inhibition of AMV reverse transcriptase activity assessed as incorporation of dTMP in poly(rA)-oligo(dT) at 1000 uM | | AID | 400988 | | BioAssay type | other | | Target | | | PubMed | | | Data Table | |
|
| 29 | [SID103215315] | Unspecified | | | Inhibition of AMV reverse transcriptase activity assessed as incorporation of dGMP in poly(rC)-oligo(dG) at 0.1 uM [AID400989, Type: other] | | View X | Row No. | 29 | | Structure |
| | Substance | | | SID | 103215315 | | CID | 122738 | | Outcome | Unspecified | | BioAssay | Inhibition of AMV reverse transcriptase activity assessed as incorporation of dGMP in poly(rC)-oligo(dG) at 0.1 uM | | AID | 400989 | | BioAssay type | other | | Target | | | PubMed | | | Data Table | |
|
| 30 | [SID103215315] | Unspecified | | | Inhibition of AMV reverse transcriptase activity assessed as incorporation of dGMP in poly(rC)-oligo(dG) at 1 uM [AID400990, Type: other] | | View X | Row No. | 30 | | Structure |
| | Substance | | | SID | 103215315 | | CID | 122738 | | Outcome | Unspecified | | BioAssay | Inhibition of AMV reverse transcriptase activity assessed as incorporation of dGMP in poly(rC)-oligo(dG) at 1 uM | | AID | 400990 | | BioAssay type | other | | Target | | | PubMed | | | Data Table | |
|
| 31 | [SID103215315] | Unspecified | | | Inhibition of AMV reverse transcriptase activity assessed as incorporation of dGMP in poly(rC)-oligo(dG) at 10 uM [AID400991, Type: other] | | View X | Row No. | 31 | | Structure |
| | Substance | | | SID | 103215315 | | CID | 122738 | | Outcome | Unspecified | | BioAssay | Inhibition of AMV reverse transcriptase activity assessed as incorporation of dGMP in poly(rC)-oligo(dG) at 10 uM | | AID | 400991 | | BioAssay type | other | | Target | | | PubMed | | | Data Table | |
|
| 32 | [SID103215315] | Unspecified | | | Inhibition of AMV reverse transcriptase activity assessed as incorporation of dGMP in poly(rC)-oligo(dG) at 100 uM [AID400992, Type: other] | | View X | Row No. | 32 | | Structure |
| | Substance | | | SID | 103215315 | | CID | 122738 | | Outcome | Unspecified | | BioAssay | Inhibition of AMV reverse transcriptase activity assessed as incorporation of dGMP in poly(rC)-oligo(dG) at 100 uM | | AID | 400992 | | BioAssay type | other | | Target | | | PubMed | | | Data Table | |
|
| 33 | [SID103215315] | Unspecified | | | Inhibition of AMV reverse transcriptase activity assessed as incorporation of dGMP in poly(rC)-oligo(dG) at 1000 uM [AID400993, Type: other] | | View X | Row No. | 33 | | Structure |
| | Substance | | | SID | 103215315 | | CID | 122738 | | Outcome | Unspecified | | BioAssay | Inhibition of AMV reverse transcriptase activity assessed as incorporation of dGMP in poly(rC)-oligo(dG) at 1000 uM | | AID | 400993 | | BioAssay type | other | | Target | | | PubMed | | | Data Table | |
|
| 34 | [SID103215315] | Unspecified | | | Binding affinity to bradykinin [AID401340, Type: Literature] | | View X | Row No. | 34 | | Structure |
| | Substance | | | SID | 103215315 | | CID | 122738 | | Outcome | Unspecified | | BioAssay | Binding affinity to bradykinin | | AID | 401340 | | BioAssay type | Literature | | Target | | | PubMed | 8991956 | | Data Table | |
|
| 35 | [SID103215315] | Unspecified | | | Antimicrobial activity against Streptococcus pyogenes [AID380211, Type: Literature] | | View X | Row No. | 35 | | Structure |
| | Substance | | | SID | 103215315 | | CID | 122738 | | Outcome | Unspecified | | BioAssay | Antimicrobial activity against Streptococcus pyogenes | | AID | 380211 | | BioAssay type | Literature | | Target | | | PubMed | 10425115 | | Data Table | |
|
| 36 | [SID103215315] | Unspecified | | | Antimicrobial activity against Candida albicans [AID380212, Type: Literature] | | View X | Row No. | 36 | | Structure |
| | Substance | | | SID | 103215315 | | CID | 122738 | | Outcome | Unspecified | | BioAssay | Antimicrobial activity against Candida albicans | | AID | 380212 | | BioAssay type | Literature | | Target | | | PubMed | 10425115 | | Data Table | |
|
| 37 | [SID103215315] | Unspecified | | | Antimicrobial activity against Staphylococcus aureus [AID380213, Type: Literature] | | View X | Row No. | 37 | | Structure |
| | Substance | | | SID | 103215315 | | CID | 122738 | | Outcome | Unspecified | | BioAssay | Antimicrobial activity against Staphylococcus aureus | | AID | 380213 | | BioAssay type | Literature | | Target | | | PubMed | 10425115 | | Data Table | |
|
| 38 | [SID103215315] | Unspecified | | | Antioxidant activity assessed as trolox equivalent by TEAC assay [AID456317, Type: Literature] | | View X | Row No. | 38 | | Structure |
| | Substance | | | SID | 103215315 | | CID | 122738 | | Outcome | Unspecified | | BioAssay | Antioxidant activity assessed as trolox equivalent by TEAC assay | | AID | 456317 | | BioAssay type | Literature | | Target | | | PubMed | 19944611 | | Data Table | |
|
| 39 | [SID103215315] | Unspecified | | | Inhibition against HIV- reverse transcriptase in cell culture at 20 ug/mL [AID82969, Type: other] | Reverse transcriptase/RNaseH [gi:82310930] | View X | Row No. | 39 | | Structure |
| | Substance | | | SID | 103215315 | | CID | 122738 | | Outcome | Unspecified | | BioAssay | Inhibition against HIV- reverse transcriptase in cell culture at 20 ug/mL | | AID | 82969 | | BioAssay type | other | | Target | Reverse transcriptase/RNaseH [gi:82310930] | | PubMed | | | Data Table | |
|
| 40 | [SID103215315] | Inactive | | | Antiadherent activity against P-fimbriated Escherichia coli in human erythrocyte assessed as suppression of agglutination using latex beads coated with P receptor analogue at 2.4 mg/ml [AID377249, Type: Literature] | | View X | Row No. | 40 | | Structure |
| | Substance | | | SID | 103215315 | | CID | 122738 | | Outcome | Inactive | | BioAssay | Antiadherent activity against P-fimbriated Escherichia coli in human erythrocyte assessed as suppression of agglutination using latex beads coated with P receptor analogue at 2.4 mg/ml | | AID | 377249 | | BioAssay type | Literature | | Target | | | PubMed | 11000024 | | Data Table | |
|
| 41 | [SID103215315] | Inactive | | | Antiadherent activity against P-fimbriated Escherichia coli in human erythrocyte assessed as suppression of agglutination using latex beads coated with P receptor analogue at 1.2 mg/ml [AID377250, Type: Literature] | | View X | Row No. | 41 | | Structure |
| | Substance | | | SID | 103215315 | | CID | 122738 | | Outcome | Inactive | | BioAssay | Antiadherent activity against P-fimbriated Escherichia coli in human erythrocyte assessed as suppression of agglutination using latex beads coated with P receptor analogue at 1.2 mg/ml | | AID | 377250 | | BioAssay type | Literature | | Target | | | PubMed | 11000024 | | Data Table | |
|
| 42 | [SID103215315] | Inactive | | | Antiadherent activity against P-fimbriated Escherichia coli in human erythrocyte assessed as suppression of agglutination using latex beads coated with P receptor analogue at 0.6 mg/ml [AID377251, Type: Literature] | | View X | Row No. | 42 | | Structure |
| | Substance | | | SID | 103215315 | | CID | 122738 | | Outcome | Inactive | | BioAssay | Antiadherent activity against P-fimbriated Escherichia coli in human erythrocyte assessed as suppression of agglutination using latex beads coated with P receptor analogue at 0.6 mg/ml | | AID | 377251 | | BioAssay type | Literature | | Target | | | PubMed | 11000024 | | Data Table | |
|
| 43 | [SID103215315] | Inactive | | | Antiadherent activity against P-fimbriated Escherichia coli in human erythrocyte assessed as suppression of agglutination using latex beads coated with P receptor analogue at 0.3 mg/ml [AID377252, Type: Literature] | | View X | Row No. | 43 | | Structure |
| | Substance | | | SID | 103215315 | | CID | 122738 | | Outcome | Inactive | | BioAssay | Antiadherent activity against P-fimbriated Escherichia coli in human erythrocyte assessed as suppression of agglutination using latex beads coated with P receptor analogue at 0.3 mg/ml | | AID | 377252 | | BioAssay type | Literature | | Target | | | PubMed | 11000024 | | Data Table | |
|
| 44 | [SID103215315] | Inactive | | | Antiadherent activity against P-fimbriated Escherichia coli in human erythrocyte assessed as suppression of agglutination using latex beads coated with P receptor analogue at 0.15 mg/ml [AID377253, Type: Literature] | | View X | Row No. | 44 | | Structure |
| | Substance | | | SID | 103215315 | | CID | 122738 | | Outcome | Inactive | | BioAssay | Antiadherent activity against P-fimbriated Escherichia coli in human erythrocyte assessed as suppression of agglutination using latex beads coated with P receptor analogue at 0.15 mg/ml | | AID | 377253 | | BioAssay type | Literature | | Target | | | PubMed | 11000024 | | Data Table | |
|
| 45 | [SID103215315] | Inactive | IC50 | | Inhibition of PHA-stimulated human PBMC proliferation assessed as [3H]thymidine uptake after 3 days by scintillation counting [AID338965, Type: Literature] | | View X | Row No. | 45 | | Structure |
| | Substance | | | SID | 103215315 | | CID | 122738 | | Outcome | Inactive | | IC50 | [uM] | | BioAssay | Inhibition of PHA-stimulated human PBMC proliferation assessed as [3H]thymidine uptake after 3 days by scintillation counting | | AID | 338965 | | BioAssay type | Literature | | Target | | | PubMed | 11975489 | | Data Table | |
|
| 46 | [SID103215315] | Inactive | | | Antiviral activity against HSV up to 200 ug/mL by extracellular virucidal assay [AID380204, Type: Literature] | | View X | Row No. | 46 | | Structure |
| | Substance | | | SID | 103215315 | | CID | 122738 | | Outcome | Inactive | | BioAssay | Antiviral activity against HSV up to 200 ug/mL by extracellular virucidal assay | | AID | 380204 | | BioAssay type | Literature | | Target | | | PubMed | 10425115 | | Data Table | |
|
| 47 | [SID103215315] | Inactive | IC50 | | Modulation of alternative complement pathway system assessed as hemoglobin release by spectrophotometry [AID380220, Type: Literature] | | View X | Row No. | 47 | | Structure |
| | Substance | | | SID | 103215315 | | CID | 122738 | | Outcome | Inactive | | IC50 | [uM] | | BioAssay | Modulation of alternative complement pathway system assessed as hemoglobin release by spectrophotometry | | AID | 380220 | | BioAssay type | Literature | | Target | | | PubMed | 10425115 | | Data Table | |
|
| 48 | [SID103215315] | Inconclusive | | | Therapeutic index was determined; Not determined [AID235746, Type: other] | | View X | Row No. | 48 | | Structure |
| | Substance | | | SID | 103215315 | | CID | 122738 | | Outcome | Inconclusive | | BioAssay | Therapeutic index was determined; Not determined | | AID | 235746 | | BioAssay type | other | | Target | | | PubMed | | | Data Table | |
|
Chemical Probe 
Active 
Inactive 
Inconclusive 
Unspecified 
